351593 <common-name>2-[[5-[(4-tert-butylphenoxy)methyl]-4-(2-methylphenyl)-1,2,4-triazol-3-yl]sulfanyl]-n-(2,4,6-trimethylphenyl)acetamide</common-name> <description>2-[[5-[(4-tert-butylphenoxy)methyl]-4-(2-methylphenyl)-1,2,4-triazol-3-yl]sulfanyl]-n-(2,4,6-trimethylphenyl)acetamide is a chemical compound with the formula C31H36N4O2S. With an average molecular weight of 528.70 g/mol, 2-[[5-[(4-tert-butylphenoxy)methyl]-4-(2-methylphenyl)-1,2,4-triazol-3-yl]sulfanyl]-n-(2,4,6-trimethylphenyl)acetamide is a heavy molecule.</description> <cas>539808-86-1</cas> <pubchem-id>4404242</pubchem-id> <chemical-formula>C31H36N4O2S</chemical-formula> <weight>528.7</weight> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-08-31T17:23:12Z</created-at> <updated-at type="dateTime">2026-08-31T17:23:12Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id nil="true"/> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>CC1=CC=CC=C1N2C(=NN=C2SCC(=O)NC3=C(C=C(C=C3C)C)C)COC4=CC=C(C=C4)C(C)(C)C</moldb-smiles> <moldb-formula>C31H36N4O2S</moldb-formula> <moldb-inchi>InChI=1S/C31H36N4O2S/c1-20-16-22(3)29(23(4)17-20)32-28(36)19-38-30-34-33-27(35(30)26-11-9-8-10-21(26)2)18-37-25-14-12-24(13-15-25)31(5,6)7/h8-17H,18-19H2,1-7H3,(H,32,36)</moldb-inchi> <moldb-inchikey>FOHMAFWCPHVVMH-UHFFFAOYSA-N</moldb-inchikey> <moldb-average-mass type="decimal" nil="true"/> <moldb-mono-mass type="decimal">528.2558976</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>7.5</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM347486</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>2-[[5-[(4-tert-butylphenoxy)methyl]-4-(2-methylphenyl)-1,2,4-triazol-3-yl]sulfanyl]-n-(2,4,6-trimethylphenyl)acetamide</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom>Organic compounds</kingdom> <superklass>Organoheterocyclic compounds</superklass> <klass>Azoles</klass> <subklass>Triazoles</subklass> <paper-count type="integer" nil="true"/> <sync-id>CED0301893</sync-id> <structure-inchikey>FOHMAFWCPHVVMH-UHFFFAOYSA-N</structure-inchikey> <structure-fingerprint>404000000000800002002800000000000000000000080000000001000000000000000002200004000000002480800000000000000000000000000000000000000000000000000100000000000022000000000104000200000050000000000000010000000000000000100000000000000100000000000000000000000000000040000800800000004002000080080000000100000000000000000000000100000000001000000000080100000040000000490000000000002400000000000800000000000001000000010000400000010000002010000200000000000000008100000000000040000000000400000000410000000041000000000000</structure-fingerprint> <structure-pattern-fingerprint>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</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAmAAAAKQAAAIABBgBgAAAAAQMGQCgAAAAD BAZAaAAAAAMDAQZAaAAAAAMDAQZAaAAAAAMDAQZAaAAAAAMDAQZAKAAAAAME B0AoAAAAAwMGQCgAAAADBAdAKAAAAAMDB0AoAAAAAwMGQCgAAAADBBAAIAAA AAIGAGAAAAACAgYAKAAAAAMECAAoAAAAAwIHAGgAAAADAgEGQCgAAAADBAZA KAAAAAMEBkBoAAAAAwMBBkAoAAAAAwQGQGgAAAADAwEGQCgAAAADBAYAYAAA AAEDBgBgAAAAAQMGAGAAAAABAwYAYAAAAAICCAAoAAAAAwIGQCgAAAADBAZA aAAAAAMDAQZAaAAAAAMDAQZAKAAAAAMEBkBoAAAAAwMBBkBoAAAAAwMBBgAg AAAABAYAYAAAAAEDBgBgAAAAAQMGAGAAAAABAwsAAQABAmgMAgNoDAMEaAwE BWgMBQZoDAYHIAcIaAwICWgMCQpoDAoLaAwLDAAMDQANDgAODygCDhAgEBEg ERJoDBITaAwTFGgMFBVoDBUWaAwWFwAUGAASGQAIGgAaGwAbHCAcHWgMHR5o DB4faAwfIGgMICFoDB8iACIjACIkACIlAAYBaAwLB2gMFhFoDCEcaAxCBAAA AAYBBgUEAwIFCQgHCwoGEhMUFRYRBh0eHyAhHBcEAAAAAAAAABY= </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T05:49:29Z</structure-indexed-at> </compound>